FF vs REX vs GPRE vs BIOX vs BG

For growth investors, Bunge Global S.

A. (BG) is the stronger pick with 32. 4% revenue growth year-over-year, versus -60. 7% for FutureFuel Corp. (FF). Bunge Global S. A. (BG) offers the better valuation at 25. 2x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate FutureFuel Corp. (FF) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Bunge Global S.

A. (BG) is the cheapest at 25. 2x versus REX American Resources Corporation at 29. 5x. On forward P/E, Bunge Global S. A. is actually cheaper at 14. 4x.

Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.

0%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: REX returned +464. 7% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Bunge Global S.

A. (BG) is the lower-risk stock at 0. 25β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately 684% more volatile than BG relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 97% for Bunge Global S. A. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Bunge Global S.

A. (BG) is pulling ahead at 32. 4% versus -60. 7% for FutureFuel Corp. (FF). On earnings-per-share growth, the picture is similar: REX American Resources Corporation grew EPS -4. 9% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BG leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

REX American Resources Corporation (REX) is the more profitable company, earning 9.

1% net margin versus -51. 6% for FutureFuel Corp. — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus -55. 3% for FF. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Bunge Global S.

A. (BG) trades at 14. 4x forward P/E versus 62. 8x for REX American Resources Corporation — 48. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for REX: 23. 3% to $60. 00.

In this comparison, BG (2.

2% yield) pays a dividend. FF, REX, GPRE, BIOX do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Bunge Global S.

A. (BG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 25), 2. 2% yield, +140. 3% 10Y return). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BG: +140. 3%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (FF (Basic Materials) and REX (Basic Materials) and GPRE (Basic Materials) and BIOX (Basic Materials) and BG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FF is a small-cap quality compounder stock; REX is a small-cap quality compounder stock; GPRE is a small-cap quality compounder stock; BIOX is a small-cap quality compounder stock; BG is a mid-cap high-growth stock. BG pays a dividend while FF, REX, GPRE, BIOX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.